Patient-Reported Outcomes: Open-Label Trials Can Be Designed To Minimize Bias, US FDA Says

 
• By Sue Sutter
  
Patient experience data
Even in an open-label trials, patients should be asked about their experience with a cancer drug. • Source: Shutterstock

More from Product Reviews

More from Pink Sheet